Vericel Corp (VCEL) stock
VCELNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 14/30325% above fair value
$57.48+0.52 (+0.91%)
Close on Nov 16, 2026Market cap $2.94BP/E 136.9Yield –
Vericel market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Vericel's market cap was $3.04B on Nov 11, 2026, against $2.03B a year earlier. Over the last 5 years it ranged from $1.08B to $3.04B, with a median of $1.82B.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $3.04B | +67.1% |
| 2025 | Dec 31, 2025 | $1.82B | -32.7% |
| 2024 | Dec 31, 2024 | $2.71B | +59.3% |
| 2023 | Dec 29, 2023 | $1.70B | +36.6% |
| 2022 | Dec 30, 2022 | $1.24B | -32.4% |
| 2021 | Dec 31, 2021 | $1.84B | +31.3% |
| 2020 | Dec 31, 2020 | $1.40B | +80.6% |
| 2019 | Dec 31, 2019 | $774.65M | +3.1% |
| 2018 | Dec 31, 2018 | $751.16M | +295.5% |
| 2017 | Dec 29, 2017 | $189.94M | +166.2% |
| 2016 | Dec 30, 2016 | $71.36M | +16.3% |
| 2015 | Dec 31, 2015 | $61.37M | -15.1% |
| 2014 | Dec 31, 2014 | $72.31M | +418.0% |
| 2013 | Dec 31, 2013 | $13.96M | -74.7% |
| 2012 | Dec 31, 2012 | $55.17M | +22.6% |
| 2011 | Dec 30, 2011 | $45.01M | -28.9% |
| 2010 | Dec 31, 2010 | $63.31M | +42.8% |
| 2009 | Dec 31, 2009 | $44.33M | – |
See a number that looks wrong?